Curran CS - Search Results

1

Inflammation and DKK1-induced AKT activation contribute to endothelial dysfunction following NR2F2 loss.

Dougherty EJ, Chen LY, Awad KS, Ferreyra GA, Demirkale CY, Keshavarz A, Gairhe S, Johnston KA, Hicks ME, Sandler AB, Curran CS, Krack JM, Ding Y, Suffredini AF, Solomon MA, Elinoff JM, Danner RL. Dougherty EJ, et al. Among authors: curran cs. Am J Physiol Lung Cell Mol Physiol. 2023 Jun 1;324(6):L783-L798. doi: 10.1152/ajplung.00171.2022. Epub 2023 Apr 11. Am J Physiol Lung Cell Mol Physiol. 2023. PMID: 37039367 Free PMC article.

2

Anti-PD-L1 therapy altered inflammation but not survival in a lethal murine hepatitis virus-1 pneumonia model.

Curran CS, Cui X, Li Y, Jeakle M, Sun J, Demirkale CY, Minkove S, Hoffmann V, Dhamapurkar R, Chumbris S, Bolyard C, Iheanacho A, Eichacker PQ, Torabi-Parizi P. Curran CS, et al. Front Immunol. 2024 Jan 8;14:1308358. doi: 10.3389/fimmu.2023.1308358. eCollection 2023. Front Immunol. 2024. PMID: 38259435 Free PMC article.

3

The complexity of nicotinamide adenine dinucleotide (NAD), hypoxic, and aryl hydrocarbon receptor cell signaling in chronic kidney disease.

Curran CS, Kopp JB. Curran CS, et al. J Transl Med. 2023 Oct 9;21(1):706. doi: 10.1186/s12967-023-04584-8. J Transl Med. 2023. PMID: 37814337 Free PMC article. Review.

4

Nicotinamide Antagonizes Lipopolysaccharide-Induced Hypoxic Cell Signals in Human Macrophages.

Curran CS, Dougherty EJ, Cui X, Li Y, Jeakle M, Gamble T, Demirkale CY, Torabi-Parizi P. Curran CS, et al. J Immunol. 2023 Jul 15;211(2):261-273. doi: 10.4049/jimmunol.2200552. J Immunol. 2023. PMID: 37314413 Free PMC article.

5

RAGE pathway activation and function in chronic kidney disease and COVID-19.

Curran CS, Kopp JB. Curran CS, et al. Front Med (Lausanne). 2022 Aug 9;9:970423. doi: 10.3389/fmed.2022.970423. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36017003 Free PMC article. Review.

6

Emulating the Effective Ankle Stiffness of Commercial Prosthetic Feet Using a Robotic Prosthetic Foot Emulator.

Halsne EG, Curran CS, Caputo JM, Hansen AH, Hafner BJ, Morgenroth DC. Halsne EG, et al. Among authors: curran cs. J Biomech Eng. 2022 Nov 1;144(11):111009. doi: 10.1115/1.4054834. J Biomech Eng. 2022. PMID: 35722979

7

Prosthetic forefoot and heel stiffness across consecutive foot stiffness categories and sizes.

Turner AT, Halsne EG, Caputo JM, Curran CS, Hansen AH, Hafner BJ, Morgenroth DC. Turner AT, et al. Among authors: curran cs. PLoS One. 2022 May 10;17(5):e0268136. doi: 10.1371/journal.pone.0268136. eCollection 2022. PLoS One. 2022. PMID: 35536854 Free PMC article.

8

Comparing forefoot and heel stiffnesses across commercial prosthetic feet manufactured for individuals with varying body weights and foot sizes.

Ruxin TR, Halsne EG, Turner AT, Curran CS, Caputo JM, Hansen AH, Hafner BJ, Morgenroth DC. Ruxin TR, et al. Among authors: curran cs. Prosthet Orthot Int. 2022 Oct 1;46(5):425-431. doi: 10.1097/PXR.0000000000000131. Epub 2022 Apr 8. Prosthet Orthot Int. 2022. PMID: 35426860

9

Effects of shear force reduction during mechanical testing and day-to-day variation on stiffness of commercial prosthetic feet: a technical note.

Halsne EG, Turner AT, Curran CS, Hansen AH, Hafner BJ, Caputo JM, Morgenroth DC. Halsne EG, et al. Among authors: curran cs. Prosthet Orthot Int. 2022 Apr 1;46(2):206-211. doi: 10.1097/PXR.0000000000000088. Prosthet Orthot Int. 2022. PMID: 35412527

10

Aryl Hydrocarbon Receptor Mechanisms Affecting Chronic Kidney Disease.

Curran CS, Kopp JB. Curran CS, et al. Front Pharmacol. 2022 Feb 14;13:782199. doi: 10.3389/fphar.2022.782199. eCollection 2022. Front Pharmacol. 2022. PMID: 35237156 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36 results

Search Page

Filters